Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

1054 results about "Eye drop" patented technology

Eye drops are saline-containing drops used as an ocular route to administer. Depending on the condition being treated, they may contain steroids, antihistamines, sympathomimetics, beta receptor blockers, parasympathomimetics, parasympatholytics, prostaglandins, nonsteroidal anti-inflammatory drugs (NSAIDs), antibiotics, antifungal, or topical anesthetics. Eye drops sometimes do not have medications in them and are only lubricating and tear-replacing solutions.

Exosome-containing eye drops as well as preparation method and application thereof

The invention relates to eye drops containing exosomes and a preparation method and application thereof, and belongs to the technical field of eye drop preparation, the eye drops comprise exosome freeze-dried powder, the exosome freeze-dried powder is prepared from the exosomes obtained after mesenchymal stem cells are treated with TNF-alpha and IFN-alpha, and a herba houttuyniae extract, the eye drops provided by the invention can inhibit the phenotype of macrophage M1 and promote the M1 to be converted into the phenotype of M2; human corneal cell proliferation, migration and damage repair are promoted; mouse cornea injury repair is accelerated; the eye drops can be used for treating xerophthalmia, conjunctivitis and keratitis, and can also be used for preventing eye diseases and relieving asthenopia; the eye drops disclosed by the invention contain the exosome obtained after the mesenchymal stem cells are treated by the TNF-alpha and the IFN-alpha, so that the anti-inflammatory ability is stronger; the mesenchymal stem cell exosome and the herba houttuyniae extract are stored in a freeze-dried form, so that the activity is stable, and the storage time is long; in addition, the cordate houttuynia is cooperated with the exosome, so that the effect playing time can be prolonged, and the use frequency is reduced.
Owner:MIWAIMI (ZHANGJIAGANG) BIOTECHNOLOGY CO LTD +1

Preparation of solid cyclodextrin complexes for ophthalmic active pharmaceutical ingredient delivery

The present disclosure relates to ophthalmic compositions containing solid complexes of active pharmaceutical ingredient and cyclodextrin, to their method of preparation and their uses. The compositions can include an active agent drug / cyclodextrin complex substantially dissolved in an aqueous eye drop vehicle. The ophthalmic composition is generally in the form of a microsuspension including an active agent complex having a diameter of less than about 100 μm.
Owner:OCULIS OPERATIONS SARL

Multidose ophthalmic compositions

The present invention relates to aqueous cyclodextrin compositions containing drug / cyclodextrin complexes and sorbic acid or a pharmaceutically acceptable sorbate that exhibit a superior antimicrobial preservation effect at a low preservative concentration, and to an aqueous eye drop microsuspension containing solid drug / cyclodextrin complexes and sorbic acid or a pharmaceutically acceptable sorbate, which is suitable as a multidose formulation.
Owner:OCULIS OPERATIONS SARL

Carboxymethyl chitosan-hyaluronic acid-stem cell exosome eye drops as well as preparation method and application thereof

The invention discloses carboxymethyl chitosan-hyaluronic acid-stem cell exosome eye drops as well as a preparation method and application thereof, and relates to the technical field of eye drops and medical biogel. The carboxymethyl chitosan-hyaluronic acid-stem cell exosome eye drops are prepared from tannic acid modified carboxymethyl chitosan and adipose tissue-derived stromal cell exosome freeze-dried powder, the carboxymethyl chitosan-hyaluronic acid-stem cell exosome eye drops provided by the invention can effectively treat xerophthalmia, and are stable in components, safe and reliable. The three components including the tannic acid modified carboxymethyl chitosan, the hyaluronic acid and the adipose tissue-derived stromal cell exosome coexist, so that the functions of all the components can be fully played, a synergistic effect is achieved, and a better treatment effect on xerophthalmia is achieved.
Owner:BIOLOGY INST OF SHANDONG ACAD OF SCI

Method of treating diabetic macular edema

The present disclosure relates to a method of treating diabetic macular edema in a human subject in need thereof, said method comprising(i) an induction phase of topically administering to an affected eye of said subject, an eye drop formulation comprising 1.5% (w / v) dexamethasone, at a dosing of 5 to 7 drops a day for 3, 4, 5, 6 weeks, followed by,(ii) a maintenance phase of topically administering to an affected eye of said subject, said eye drop formulation comprising 1.5% (w / v) dexamethasone at a daily dosing less frequent than the induction phase for example 1-3 drops.
Owner:OCULIS OPERATIONS SARL

Liquid chromatography detection method and system for eye drops

The invention discloses a liquid chromatography detection method and system for eye drops, and relates to the technical field of chromatographic detection.The liquid chromatography detection method comprises the steps that liquid chromatography analysis is conducted to obtain an original chromatographic signal; performing adaptive baseline correction on the original chromatographic signal to obtain a corrected chromatographic signal, synchronizing the corrected chromatographic signal to a chromatographic peak identification analysis model for identification to obtain a plurality of chromatographic peaks including principal component peaks and specific impurity peaks, and performing calculation to obtain a first integral area of the principal component peaks and a second integral area of the specific impurity peaks; the preset correction factor is combined with the first integral area and the second integral area to automatically carry out quantitative calculation on the eye drops, and a liquid chromatogram detection report of the eye drops is generated. The technical problems that in the prior art, main component peak and impurity peak recognition and quantification depend on manual processing in the eye drop liquid chromatogram detection process, and accuracy and consistency are insufficient are solved, and the technical effects that the accuracy and automation level of eye drop liquid chromatogram detection are improved, and it is guaranteed that main component and impurity quantification results are stable and consistent are achieved.
Owner:JIANGSU TIANPING PHARM CO LTD

Eye drops containing recombinant protein as well as preparation method and application of eye drops

The invention relates to the technical field of biological medicine, in particular to eye drops containing recombinant protein as well as a preparation method and application of the eye drops. Comprising the following components: 0.01%-1% of recombinant human TFF3 protein, 0.1%-1% of an osmotic pressure regulator, 0.08%-2% of a pH regulator, 0.05%-0.15% of a thickening agent, 0.01%-0.1% of a surfactant, 0.01%-0.1% of a protective agent and the balance of water for injection, the traditional Chinese medicine composition can be used for treating the xerophthalmia, can promote wound healing and cell migration, has the effects of inhibiting inflammation and cell apoptosis, and can act on a plurality of target spots at the same time, so that the tear film stability is improved, ocular surface inflammation is inhibited, the vicious circle of the xerophthalmia is broken, and the xerophthalmia is treated more comprehensively and effectively; the problems that in the prior art, xerophthalmia medicine targets are single, and xerophthalmia cannot be comprehensively and effectively treated are solved.
Owner:TIANJIN UNIVERSITY OF TECHNOLOGY

Nucleic acid medicine eye drops and preparation method thereof

The invention relates to nucleic acid medicine eye drops and a preparation method thereof. The nucleic acid drug eye drops comprise nucleic acid drug-loaded lipid nanoparticles and cell-penetrating peptides modified on the surfaces of the lipid nanoparticles, the lipid nanoparticle comprises a core and a surface layer, and the core comprises ionizable lipid and a phospholipid layer which are coated on the surface of the nucleic acid drug; the surface layer comprises ionizable lipid, phospholipid, cholesterol and modified polylysine; the modified polylysine is grafted with the cell-penetrating peptide. The nucleic acid drug eye drops have high stability, can realize noninvasive delivery of nucleic acid drugs, and complete treatment of posterior segment diseases of eyes.
Owner:THE EYE HOSPITAL OF WENZHOU MEDICAL UNIVERSITY

Bifidobacterium animalis for relieving eye allergy and application thereof

PendingCN121592551ASenses disorderBacteriaDiseaseSwollen eyelid
The invention belongs to the technical field of microorganisms, and particularly relates to bifidobacterium animalis for relieving eye allergy and application of the bifidobacterium animalis. The invention provides an application of bifidobacterium animalis subsp. Lactis in preparation of a product for relieving eye allergy, the bifidobacterium animalis subsp. Lactis is Def +, and the preservation number is CGMCC (China General Microbiological Culture Collection Center) No.35798. The Bifidobacterium animalis subsp. Lactis Def < + > provided by the invention can relieve the eye itching symptom, relieve red and swollen eyelids, reduce conjunctiva and cornea injury, relieve eye discomfort, relieve globular conjunctivitis cell infiltration, improve corneal epithelium thickening lesion, improve the anti-inflammatory ability and improve allergic conjunctivitis, keratitis and blepharitis marginata in a targeted manner. The eye drops are high in safety and resistant to gastrointestinal fluid, and a safe and long-acting scheme is provided for eye allergic diseases.
Owner:ZHONGKE WISBIOM(BEIJING)BIOTECHNOLOGY CO LTD

Preparation method of eye drops for treating glaucoma, cataract and vitreous opacification

The invention discloses a preparation method of eye drops for treating glaucoma, cataract and vitreous opacification. The eye drops comprise the following components: berberine, N-acetyl carnosine and lycium barbarum polysaccharide. The specific formula comprises the following components: 0.1%-0.5% of berberine, 1%-3% of N-acetyl carnosine and 0.5%-2% of lycium barbarum polysaccharide. The invention belongs to the technical field of ophthalmic pharmaceutical preparations, and solves the problems that in the prior art, glaucoma, cataract and vitreous opacity generally need to be separately taken, the research on compound preparations is less, and the components possibly interact with one another.
Owner:JIANGXI DONGGE HEALTH PRODUCTS CO LTD

Carrier-free nanoparticles with synergistic effect of Chinese and western medicines as well as preparation method and application of carrier-free nanoparticles

The invention relates to the field of biological medicine, in particular to a carrier-free nanoparticle which is formed by self-assembly of cyclosporine A and costunolide through intermolecular weak interaction. The invention also provides a preparation method of the traditional Chinese medicine composition and application of the traditional Chinese medicine composition in preparation of medicines for treating xerophthalmia. The carrier-free nano eye drops based on the synergistic effect of Chinese and western medicines are used for anti-inflammatory treatment of the xerophthalmia, a new strategy is provided for precise diagnosis and treatment of the xerophthalmia, the problems of single target spot, limited curative effect and the like in traditional treatment are solved, and more efficient inflammation control is expected to be achieved. While the curative effect is improved, the tolerance risk caused by long-term use is reduced, double optimization of the curative effect and safety is realized, and the limitation of traditional single drug treatment is broken through. By adopting the carrier-free nano preparation, the delivery efficiency of the medicine on the ocular surface is effectively improved, the bioavailability is enhanced, powerful support is provided for improving the curative effect of the medicine, and the carrier limitation bottleneck is broken through.
Owner:SHANGHAI YANGPU SHIDONG HOSPITAL

Composition for protecting eyes and strengthening brain as well as preparation method and application of composition

The invention relates to the technical field of functional food, in particular to an eye-protecting and brain-strengthening composition as well as a preparation method and application thereof. The aronia, the astaxanthin, the DHA, the medlar, the hovenia dulcis thunb and the saffron crocus extract are compounded, various functional raw materials have a synergistic effect, the visual problem is improved through multiple channels, the cognitive ability is synchronously improved, and the astaxanthin eye drops have the effects of preventing retina oxidative damage, promoting eye blood circulation, relieving visual fatigue, protecting nerve cells and improving the cognitive state. Through reasonable proportioning, the composition for protecting eyes and strengthening brain has better effects of relieving visual discomfort, improving vision and improving brain health.
Owner:SHANGHAI PUGUANG SHINING HEALTH TECH CO LTD

Preparation method of voriconazole hydrogel and eye drops using the same

In response to poor solubility and permeability of conventional voriconazole eye drops and short retention time thereof at the ocular surface, a preparation method of voriconazole hydrogel and eye drops using the same are provided. The preparation method includes steps of: adding DAPA and sodium hydroxide to deionized water, stirring until completely dissolved to produce a DAPA solution; dropping the DAPA solution into triformylbenzene ethanol solution, and reacting at room temperature; then centrifugating, washing precipitation with ethanol, and freeze-drying in vacuum, so as to obtain a polyaldehyde oligomer; and reacting the polyaldehyde oligomer with AHA to synthesize the voriconazole hydrogel. A preparation method of a topical ocular drug includes: applying a therapeutically effective amount the voriconazole hydrogel, wherein the topical ocular drug is for mechanical injury or fungal keratitis. The present invention improves aqueous solubility, penetration, and ocular surface retention time of VCZ.
Owner:EYE INSTITUTE OF SHANDONG FIRST MEDICAL UNIVERSITY (SHANDONG EYE INSTITUTE QINGDAO EYE HOSPITAL

Azastine hydrochloride eye drops for treating allergic conjunctivitis and preparation method thereof

According to the nitrogen hydrochloride # imgabs0 # stine eye drops for treating allergic conjunctivitis and the preparation method of the nitrogen hydrochloride # imgabs0 # stine eye drops, the prepared eye drops can interact with the mucous layer on the surface of keratoconjunctiva by selecting specific solid lipid and a surfactant and controlling the dosage of the solid lipid and the surfactant; the retention capacity of the medicine in front of the cornea is prolonged, so that the medicine has good targeting property, the continuous release of the medicine is realized, the medication frequency can be reduced, the toxic and side effects of the medicine are reduced, the bioavailability is improved, the medication compliance of a patient is enhanced, and in the preparation and long-term storage processes, the medicine has better stability, and is suitable for popularization and application. Therefore, the problems of excessive drug due to multiple administration and poor stability of the active component nitrogen hydrochloride # imgabs1 # stine are solved.
Owner:NANJING HEALTHNICE MEDICAL TECH +3

Double-shell JAK inhibitor nanoparticle, preparation method thereof and targeted delivery eye drops

The invention relates to the technical field of pharmaceutical preparations, and provides double-shell JAK inhibitor nanoparticles, a preparation method thereof and targeted delivery eye drops. The double-shell JAK inhibitor nanoparticle provided by the invention comprises a core, an inner shell and an outer shell, wherein the core comprises a nanostructure lipid carrier and a JAK inhibitor; the inner shell layer is a cationic polymer, and the outer shell layer is hyaluronic acid. Through the design of the positive charge inner shell layer and the negative charge outer shell layer, the dual functions of mucosa adhesion and active targeting are achieved, the surface of the nanoparticle is electronegative finally, cytotoxicity possibly caused by direct exposure of a cationic polymer is reduced, non-specific aggregation of the cationic polymer and electronegative protein in tears is avoided, and the stability of tears is improved. And the stability of the preparation is improved. The eye drops provided by the invention can obviously prolong the residence time of the JAK inhibitor on the ocular surface, enhance the cornea permeability, can actively target to ocular inflammatory cells, and have a wide application prospect.
Owner:SHANDONG INOMIC INST OF PHARM RES CO LTD

Near-infrared light response in-situ gelling and photo-thermal-photodynamic synergistic gel delivery system as well as preparation method and application thereof

The invention relates to a near-infrared light response in-situ gelling and synergistic photo-thermal-photodynamic gel delivery system and a preparation method and application thereof, a mesoporous silicon coated up-conversion nano-carrier and an efficient photosensitizer are compounded to form a photo-response core unit, and then the photo-response core unit is intelligently integrated with photo-curing hydrogel to form the near-infrared light response in-situ gelling and synergistic photo-thermal-photodynamic gel delivery system. The general problem of aggregation and quenching of photosensitive molecules is relieved by utilizing the unique space confinement effect of the mesoporous structure, the ICG photo-thermal efficiency and photodynamic performance are enhanced, under precise excitation of a near-infrared light source, the system can activate a photo-crosslinking reaction through an up-conversion luminescence process, in-situ conversion from a liquid eye drop preparation to a stable gel state is achieved, and the stability of the eye drop preparation is improved. A lasting drug reservoir is formed on the surface of the cornea; synchronously excited photodynamic and photo-thermal dual-mode treatment generates a remarkable synergistic antibacterial effect, and shows an excellent removal capability on pathogens including highly drug-resistant bacteria; meanwhile, an ideal microenvironment is created for tissue repair through high biocompatibility and a stable mechanical matrix, and integrity recovery of cornea structures and functions is promoted.
Owner:NING BO EYE HOSPITAL

Composition of eye drops as well as preparation method and application of composition

The invention provides an eye drop composition as well as a preparation method and application thereof, and belongs to the technical field of ophthalmic preparations. The eye drop composition adopted by the invention is prepared from the following components: brimonidine tartrate, hyaluronic acid, collagen, trehalose and injection water. By compounding the components, the eye drops which can realize slow release of brimonidine tartrate and prolong the antihypertensive action time and have the characteristics of relieving blink discomfort, long-acting moisturizing, anti-inflammatory soothing, mildness, corrosion prevention and the like are prepared; the eye drops are beneficial to people suffering from glaucoma, intraocular hypertension, xerophthalmia, postoperative inflammation or allergy and preservative sensitivity or preservative allergy, the life quality is improved, and diseases are relieved.
Owner:JIMIN HEALTH MANAGEMENT CO LTD

Eye drops containing L-ergothioneine and preparation method thereof

The invention discloses eye drops containing L-ergothioneine and a preparation method of the eye drops. The eye drops are prepared from the following components in parts by weight: 0.0015 to 15 parts of L-ergothioneine, 0.001 to 0.01 part of a bacteriostatic agent, 0.05 to 15 parts of a buffering agent and the balance of normal saline, and the pH value of the eye drops is 5.0 to 7.0. Experiments show that L-ergothioneine can prevent and reverse denaturation of crystalline lens protein, the prepared eye drops containing L-ergothioneine can prevent and reduce opacity of crystalline lens protein, and the prevention and treatment effects on cataract are better than those of existing eye drops.
Owner:ZHEJIANG UNIV +1

Ophthalmic formulation for preventing and / or treating cataracts by eye drop administration

An ophthalmic formulation for preventing and treating cataracts contains an active substance for treating eye diseases and a pharmaceutically acceptable carrier or excipient. The active substance is oxidized cholesterol, including lanosterol or 25-hydroxycholesterol; the pharmaceutically acceptable carrier or excipient contains a surfactant, a tackifier, a cosolvent, and a solvent; the content of the oxidized cholesterol in the formulation is 0.01-5 mg / mL; and the mass ratio of the surfactant, the tackifier, the cosolvent, and the oxidized cholesterol is (1-300):(1-100):(100-3000):1, with the balance being the solvent. Upon eye drop administration, the formulation can cause the active substance to be selectively enriched in the lens of a laboratory animal to accurately exert the effect of treating cataracts. The active substance is not distributed in the aqueous humor and the vitreous body, thereby avoiding toxic and side effects on other eye tissue and the whole body.
Owner:CHENGDU RUIMU BIO PHARM TECH CO LTD

Azastine hydrochloride eye drops and preparation process thereof

The invention belongs to the field of pharmaceutical preparations, and particularly relates to nitrogen hydrochloride # imgabs0 # stine eye drops and a preparation process thereof, the nitrogen hydrochloride # imgabs0 # stine eye drops comprise 0.05% of nitrogen hydrochloride # imgabs1 # stine, 0.2-0.3% of hydroxypropyl methylcellulose, 0.1-0.2% of edetate disodium, 0.12-0.15% of an isoosmotic adjusting agent, 0.04-0.07% of a preservative and 0.005-0.0075% of choline aromatic folic acid; the nitrogen hydrochloride # imgabs2 # stine eye drops prepared by the preparation method disclosed by the invention have the advantages that the adsorption of nitrogen hydrochloride # imgabs3 # stine on a low-density polyethylene bottle is well inhibited under the condition of visible light, and the reduction of the concentration of nitrogen hydrochloride # imgabs4 # stine in the eye drops is remarkably prevented, so that the medication safety is improved. Besides, the added cholinofolic acid and hydroxypropyl methylcellulose have small irritation to eyes under a specific ratio, and can also have a large enough contact angle with the eyes of rabbits at high temperature, so that the retention property of the eye drops on the eyes can be improved, and the drug effect can be favorably exerted.
Owner:HEFEI HUAWEI PHARM CO LTD

A kind of wetting boric acid eye drops and preparation method thereof

The present invention relates to the technical field of eye drops, and specifically discloses a kind of wetting boric acid eye drops. The present invention also discloses a preparation method of the above-mentioned wetting boric acid eye drops, boric acid, chlorhexidine gluconate solution, and calcium disodium edetate are added to water, and stirred at 60-70°C to obtain a boric acid complex; sodium hyaluronate and sodium alginate are added to water and stirred, and hypromellose is added, and stirred at 30-40°C to obtain a hypromellose complex; soy lecithin, cholesterol, and ethylparaben are added to chloroform and stirred to obtain phase A; collagen and carboxymethyl chitosan are added to citric acid aqueous solution and stirred to obtain phase B; phase A is added to phase B under stirring, ultrasonic treatment, 50-60°C vacuum rotary evaporation to remove chloroform, citric acid aqueous solution is added for hydration, ultrasonic treatment, and filtration to obtain liposomes; boric acid complex, hypromellose complex, and liposomes are mixed evenly, and the pH value of the adjustment system is 6.5-7.5.
Owner:NANJING JINDUN ANIMAL PHARMA

Method and system of using NFC technology on eyewear frames, eyewear accessories, and eye drop containers to link users devices with prescriptions and information

The invention relates to an information distribution marketing ecosystem connecting eyewear, eyewear accessories, signs, stickers to present prescriptions, information or telemedicine connection capabilities based on NFC technology embedded or adapted onto products. The method and system comprising of using mobile applications to program eyeglasses or contact lenses prescriptions, weblink connection, product information, synergistic marketing, appointment scheduling links, and / or virtual audio telemedicine direct links into an NFC tag to one or more products such as signs, stickers, eyewear frames, eyewear accessories. NFC embedded products can be used in pharmacies, medical offices, optical retailer shops, department stores, or eye doctors' offices. The NFC tag on selected products and their parts helps to enable a user to use an NFC smartphone to touch the NFC tag, to reach information via centralized connection and / or decentralized connection using the internet.
Owner:GRAJALES WILLIS DENNIS

Method for detecting content of carbomer in eye drops

The invention belongs to the technical field of pharmaceutical analysis, and particularly relates to a method for detecting the content of carbomer in eye drops. The method comprises the following steps: by adopting a two-time washing and centrifugal separation mode, controlling the washing and centrifugal times, centrifugal conditions and washing volume, separating carbomer and brinzolamide from other auxiliary materials in the brinzolamide eye drops, obtaining the weights of carbomer and brinzolamide by adopting a drying and weighing mode, subtracting the weight of brinzolamide, and calculating the content of the auxiliary materials in the brinzolamide eye drops. And calculating to obtain the carbomer content in the sample. The method is suitable for detecting the carbomer content in the carbomer-containing brinzolamide eye drops, and is simple and convenient to operate, efficient, accurate and low in cost.
Owner:HUNAN PEGLAN PHARMACEUTICAL CO LTD

Eye drop propulsion device and method

An eye drop propulsion device and method for propelling a drop of fluid towards an eye, including a compression chamber connected to a container configured to retain fluid, a dispenser aperture connected to the compression chamber and configured to be selectively occluded or not occluded, and a compressor configured to alter pressure in the compression chamber such that when the compressor is activated when the dispenser aperture is occluded, air is forced to flow from the compression chamber into the container, and when the compressor is deactivated, a vacuum is created in the compression chamber causing a portion of fluid in the container to flow into the compression chamber, and when the compressor is activated when the dispenser aperture is not occluded, a drop of fluid is propelled towards the eye.
Owner:DAVIS ANDREW PETER

Anti-pollution eyedrop bottle with positioning support

The utility model discloses an anti-pollution eyedrop bottle with a positioning support. The anti-pollution eyedrop bottle comprises an anti-pollution eyedrop bottle body and the positioning support. The anti-pollution eyedrop bottle body is divided into a liquid storage area and a liquid outlet area according to the structure; the liquid storage area is cylindrical, the bottom of the liquid storage area is connected with the liquid outlet area, the liquid outlet area is conical, and a liquid outlet is formed in the bottom of the liquid outlet area; a blocking assembly and a quantifying assembly are further arranged in the anti-pollution eyedrop bottle body, the blocking assembly is used for limiting one-way circulation of liquid at the liquid outlet, and the quantifying assembly is used for ensuring constant liquid outlet every time; the outer surface of the bottom of the liquid storage area is sleeved with the positioning support, and the bottom face of the positioning support is located in the axis direction of the anti-pollution eye drop bottle body and is lower than the liquid outlet; and an isolation layer is further arranged on the outer surface of the liquid outlet and used for being isolated from the external environment. By using the device, the operation can be easily carried out, and drug use errors are avoided. Meanwhile, the sealing performance of the eyedrops in the using process is guaranteed, and pollution is reduced.
Owner:SHENYANG AIER EYE OPTOMETRY HOSPITAL CO LTD

Eye-drop oil type pharmaceutical composition

The invention relates to a pharmaceutical composition for an eye drop dosage form. The pharmaceutical composition comprises a lipid, white soft paraffin and liquid paraffin. Each gram of the ophthalmic pharmaceutical composition comprises 3 to 500 milligrams of lipid, 100 to 250 milligrams of white soft paraffin and 1 to 797 milligrams of liquid paraffin.
Owner:WINSTON MEDICAL SUPPLY

Method for detecting sodium thiosulfate pentahydrate in litamilast eye drops

PendingCN119064478AQuality assurancegood repeatabilityComponent separationSodium Thiosulfate PentahydrateEye drop
The invention belongs to the field of pharmaceutical analysis, and relates to a method for detecting antioxidant sodium thiosulfate pentahydrate in litamilast eye drops, which adopts high performance liquid chromatography for detection, adopts a chromatographic column with octadecylsilane chemically bonded silica as a filler, adopts a tetrabutylammonium bisulfate solution as a mobile phase A and acetonitrile as a mobile phase B, isocratic elution is carried out, and the content of sodium thiosulfate pentahydrate in litamilast eye drops is detected. The detection wavelength is 210-250nm, and the column temperature is 25-35 DEG C. The detection method provided by the invention can effectively detect the content of the antioxidant sodium thiosulfate pentahydrate in the litamilast eye drops, has the advantages of strong specificity, high sensitivity and accuracy, good repeatability and durability, simple operation and reliable result, and is suitable for detection and quantitative control of the sodium thiosulfate pentahydrate in the litamilast eye drops.
Owner:LUNAN BETTER PHARMA

Exosome composition, application thereof and exosome eye drops

The invention relates to an exosome composition, application thereof and exosome eye drops, and relates to the technical field of pharmaceutical preparations, and the exosome composition is composed of a mesenchymal stem cell exosome and a rabdosia lingua extract in a weight ratio of (5-10): (13-21). The exosome composition is composed of the mesenchymal stem cell exosome and the rabdosia lophanthoides extract in a proper proportion, and the mesenchymal stem cell exosome and the rabdosia lophanthoides extract are matched for use, so that the exosome composition has an excellent treatment effect on cataract and can be applied to preparation of products such as eye drops and the like, and a new treatment means is provided for cataract patients. In addition, the exosome eye drops provided by the invention do not contain side-effect components such as preservatives and hormones, have no obvious irritation and can be used for a long time.
Owner:SICHUAN XINBIXUE BIOTECHNOLOGY CO LTD

Eyedrop for treating photochemical injury of eyes and preparation method of eyedrop

The invention relates to the technical field of traditional Chinese medicines, and discloses eye drops for treating photochemically damaged eyes and a preparation method thereof. The eyedrops are prepared from the following raw materials: rhizoma polygonati, musk, flos chrysanthemi indici, semen cassiae, honeysuckle flowers, cortex phellodendri, herba houttuyniae, pearl powder, cortex fraxini, flatstem milkvetch seeds, rhizoma seu radix notopterygii and carthamin yellow. The traditional Chinese medicine composition is reasonable in component compatibility and synergistic in interaction, conforms to the traditional Chinese medicine theory, has the effects of clearing heat and purging fire, clearing liver and improving vision, clearing away heat and toxic materials and inducing diuresis to alleviate edema, can treat various eye diseases and discomfort caused by electronic equipment, and can also remarkably recover the activity of SOD and inhibit generation of MDA, so that retina lipid peroxidation caused by illumination is relieved, and the retina lipid peroxidation effect is improved. The composition has a good protection effect on the retina damaged by photochemistry, and the curative effect is remarkable.
Owner:CHEN JINJI BIOMEDICAL TECH (GUANGZHOU) CO LTD

Mesenchymal stem cell exosome eye atomization administration device

The invention belongs to the technical field of medical auxiliary equipment, and discloses a mesenchymal stem cell exosome eye atomization drug delivery device which comprises a base shell and an atomization drug delivery assembly, and the base shell is connected with a bandage, a motor and a shell; the atomization drug delivery assembly comprises a driven gear, a grooved wheel shaft, a swing connecting rod, a fixed groove body, an eye disk, a drug delivery cylinder, an eye drop bottle, a fixed plate and a sliding block, an output shaft of the motor is connected with a driving gear, and the eye disk is connected with an atomization nozzle and a silica gel sleeve provided with a protrusion; the swing connecting rod is connected with a linkage shaft, the medicine feeding cylinder is connected with a push-pull rod, and the push-pull rod is rotationally connected with the linkage shaft through a linkage rod. The whole atomization drug delivery device is worn on the head through the bandage, drug delivery is conducted on the eyes through the atomization drug delivery assembly, eyelids do not need to be opened through fingers, and drug delivery operation is simple; the dosing position and distance are fixed, the dosing effect is good, the efficiency is high, and the probability that eyedrops are polluted or eyes are infected is small.
Owner:TONGJI HOSPITAL ATTACHED TO TONGJI MEDICAL COLLEGE HUAZHONG SCI TECH